Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...
"We need more media outlets like Tansa to be established — competing as rivals where necessary, but collaborating to ...
The History Channel’s Reconstruction: The Unfinished Promise, a collaboration with Barack and Michelle Obama’s Higher Ground ...
Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets ...
Aquaponics can offer a range of benefits depending on the local context. In South Africa, townships in major cities such as Johannesburg don’t always have the space to produce their own food, while in ...
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central ...
Infosys shares soared 6% following the launch of an AI-driven editorial recommendation engine, developed in collaboration ...
Practical strategies for researchers engaging with trauma-related issues and participants with experience of trauma ...
Remedy Entertainment’s next action game appeared at yesterday’s State of Play with a release date, but it wasn’t the one that ...
Indie films, one of the city’s two major book fairs, a floral celebration, jazz, and an event for dog owners and their furry ...
Newly deployed technology rethinks how commercial air conditioning systems handle humidity — and uses novel materials to ...
Cargill Animal Nutrition and Health Sustainability Director Dave Robb confirmed that industry growth, combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results